Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access

Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic's Center for Regenerative Biotherapeutics, brings over three decades of pioneering experience in regenerative medicine to the forefront. In a detailed discussion, she outlines the critical evolution of academic medical centers in bridging the gap between scientific discovery and clinical application. The conversation explores the intricate process of translating innovative cell and gene therapies from the laboratory to patient care, emphasizing the necessity of integrated manufacturing and strategic partnerships.

Dr. Allickson addresses the logistical complexities of managing more than 30 clinical trials across three separate sites. She delves into the indispensable role of early automation and artificial intelligence as foundational strategies for enhancing scalability and significantly reducing operational costs. A central theme is the importance of incorporating considerations for commercial viability at the earliest stages of development to ensure that these groundbreaking therapies become widely accessible to patients. Hear Allickson's insights on how early automation and strategic planning are shaping the future of patient care in the full podcast episode.